Bright Non Current Liabilities Total vs Total Assets Analysis
| DRUG Stock | USD 44.00 4.82 12.30% |
Bright Minds financial indicator trend analysis is way more than just evaluating Bright Minds Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bright Minds Biosciences is a good investment. Please check the relationship between Bright Minds Non Current Liabilities Total and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Non Current Liabilities Total vs Total Assets
Non Current Liabilities Total vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bright Minds Biosciences Non Current Liabilities Total account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Bright Minds' Non Current Liabilities Total and Total Assets is 0.44. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Assets in the same time period over historical financial statements of Bright Minds Biosciences, assuming nothing else is changed. The correlation between historical values of Bright Minds' Non Current Liabilities Total and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Bright Minds Biosciences are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Current Liabilities Total i.e., Bright Minds' Non Current Liabilities Total and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.44 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Non Current Liabilities Total
Total Assets
Total assets refers to the total amount of Bright Minds assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bright Minds Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Bright Minds' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bright Minds Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. The current Selling General Administrative is estimated to decrease to about 1.3 M. The current Issuance Of Capital Stock is estimated to decrease to about 1 M
Bright Minds fundamental ratios Correlations
Click cells to compare fundamentals
Bright Minds Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bright Minds fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 880.2K | 20.0M | 12.1M | 6.9M | 7.9M | 8.8M | |
| Other Current Liab | 12.5K | 42K | 158.2K | 25K | 28.8K | 27.3K | |
| Total Current Liabilities | 150.9K | 638.6K | 1.5M | 280.9K | 323.0K | 567.5K | |
| Total Stockholder Equity | 729.3K | 19.4M | 10.5M | 6.6M | 7.6M | 8.2M | |
| Net Debt | (799.9K) | (19.8M) | (11.5M) | (6.7M) | (6.0M) | (6.3M) | |
| Retained Earnings | (559.1K) | (9.2M) | (24.2M) | (31.5M) | (28.4M) | (27.0M) | |
| Accounts Payable | 138.4K | 596.6K | 1.2M | 182.3K | 209.7K | 199.2K | |
| Cash | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M | |
| Cash And Short Term Investments | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M | |
| Liabilities And Stockholders Equity | 880.2K | 20.0M | 12.1M | 6.9M | 7.9M | 8.8M | |
| Other Stockholder Equity | 0.0 | (33.7K) | 10.5T | 831.8K | 956.6K | 908.8K | |
| Total Liab | 150.9K | 638.6K | 1.5M | 280.9K | 323.0K | 583.3K | |
| Total Current Assets | 878.2K | 20.0M | 11.9M | 6.8M | 7.8M | 8.7M | |
| Accumulated Other Comprehensive Income | 161.3K | 1.6M | 2.5M | 3.4M | 3.9M | 4.1M | |
| Common Stock | 980.7K | 27.1M | 32.2M | 33.9M | 39.0M | 20.8M |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.